Zyla Life Sciences Deferred Tax Assets, Inventory
Zyla Life Sciences had Deferred Tax Assets, Inventory of $53.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInventory · last filed 2020-03-26
- 2019-12-31: Deferred Tax Assets, Inventory $53.00K.
- 2018-12-31: Deferred Tax Assets, Inventory $75.00K.
- 2017-12-31: Deferred Tax Assets, Inventory $96.00K.
- 2016-12-31: Deferred Tax Assets, Inventory $714.00K.
| Period end | Deferred Tax Assets, Inventory |
|---|---|
| 2019-12-31 | $53.00K 10-K · filed 2020-03-26 |
| 2018-12-31 | $75.00K 10-K · filed 2020-03-26 |
| 2017-12-31 | $96.00K 10-K · filed 2019-03-29 |
| 2016-12-31 | $714.00K 10-K · filed 2018-03-16 |